Home › Medical › Bone density during transition
Bone density during transition
Adolescence is a crucial period for the build-up of peak bone mass, driven by sex hormones.
Bone mass build-up in puberty
Adolescence is a crucial period for the build-up of peak bone mass, driven by sex hormones. Suppression of puberty with GnRH agonists temporarily inhibits this build-up. Research by Vlot and colleagues (2017) showed that adolescents on puberty blockers developed a delay in bone density (BMAD) that was only partially caught up after the start of cross-sex hormones.
In adults on hormone therapy
In adult trans women on estrogen, bone density is usually maintained. In trans men on testosterone, bone density increases in some places. Risk arises when hormones are stopped without replacement — for example after orchiectomy without estrogen, or with long-term underdosing.
Recommendations for monitoring
International guidelines recommend a DEXA measurement at the start of hormone substitution and periodically during treatment, with extra attention for adolescents on puberty blockers and with long-term hormone use.
Sources
Hembree, W.C., Cohen-Kettenis, P.T., Gooren, L., et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. doi:10.1210/jc.2017-01658
Coleman, E., Radix, A.E., Bouman, W.P., et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(sup1), S1–S259. doi:10.1080/26895269.2022.2100644
Vlot, M.C., Klink, D.T., den Heijer, M., et al. (2017). Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone, 95, 11–19. doi:10.1016/j.bone.2016.11.008
Cass, H. (2024). Independent Review of Gender Identity Services for Children and Young People: Final Report. cass.independent-review.uk